Stock A287410 JEISYS MEDICAL INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Jeisys Medical Inc.

Equities

A287410

KR7287410005

End-of-day quote Korea S.E.
Other stock markets
 18:00:00 2024-05-07 EDT 		5-day change 1st Jan Change
9,840 KRW -2.96% Intraday chart for Jeisys Medical Inc. +2.18% -6.20%
04-11 AVAVA Announces Exclusive Distribution Partnership with Jeisys Medical Inc. for Korea and Japan CI
04-04 AVAVA, Inc. announced that it expects to receive $14.999999 million in funding from Jeisys Medical Inc. CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AVAVA Announces Exclusive Distribution Partnership with Jeisys Medical Inc. for Korea and Japan
CI
AVAVA, Inc. announced that it expects to receive $14.999999 million in funding from Jeisys Medical Inc.
CI
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
CI
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
CI
Jeisys Medical Inc.'s Equity Buyback announced on May 15, 2023, has closed with 1,075,838 shares, representing 1.42% for KRW 10,000.85 million.
CI
Imeik Technology Wins Exclusive Rights to Distribute Jeisys’ Aesthetic Equipment in China
MT
Tranche Update on Jeisys Medical Inc.'s Equity Buyback Plan announced on May 15, 2023.
CI
Jeisys Medical Inc. announces an Equity Buyback.
CI
Jeisys Medical Inc. authorizes a Buyback Plan.
CI
Jeisys Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023
CI
Cynosure KK Enters into Distribution Partnership with Jeisys Medical KK in Japan
CI
Jeisys Medical Inc.(KOSDAQ:A287410) added to S&P Global BMI Index
CI
SACCI Bio Co., Ltd. announced that it expects to receive KRW 2.85 billion in funding from Jeisys Medical Inc.
CI
Jeisys Medical Inc. completed the acquisition of Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others in a reverse merger transaction.
CI
Jeisys Medical Inc. signed a contract to acquire Yuanta 3 SPECIAL PURPOSE ACQUISITION CO., LTD. from Alliance Capital Partners Co., Ltd. and others for approximately KRW 300 billion in a reverse merger transaction.
CI
Jeisys Medical Inc. announced that it has received KRW 4.00043853 billion in funding from BNH Investment LLC, DAYLI Partners Co., Ltd., LSK Investment
CI
Jeisys Medical Inc. announced that it expects to receive KRW 4.00043853 billion in funding from BNH Investment LLC, DAYLI Partners, LSK Investment
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. A287410 Stock
  4. News Jeisys Medical Inc.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW